Rigorous data gives acetaminophen brands footing to reassure pregnant consumers.

The FDA is considering a change to the labels of Tylenol and other drugs containing acetaminophen. The new label would warn that using these drugs during pregnancy might be linked to a higher risk of autism and ADHD in children. Marketers in this space will want to be transparent in ads and promotional materials that their medicine contains acetaminophen since consumers are far less familiar with ingredients than prescription drug brands. Campaigns should avoid using language overstating the certainty that acetaminophen isn’t linked to autism and re-emphasize that pregnant women should always consult their doctors before taking the medicine.

The news: More than 90% of multicultural consumers use digital devices in their healthcare journeys, per a new Cadent Pharma Advertising Trends study. The takeaway: TV is still an important broad awareness media channel for pharma and healthcare companies. However, among growing diverse populations, digital and mobile advertising is more popular and spurs a desire for more information and purchasing. Marketers need to meet diverse audiences with educational and culturally relevant content.

Sanofi’s Opella secures FDA nod to pursue OTC Cialis study: If Cialis’ shift from a prescription drug to over-the-counter product comes to fruition, both consumers and D2C retailers could benefit.

Biden-Harris administration proposes expansions to the Affordable Care Act: Its timely proposal to cover over-the-counter contraception for free is a shrewd political play to sway undecided voters.